• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic lands Japanese approval for CoreValve trial | Regulatory Roundup

Medtronic lands Japanese approval for CoreValve trial | Regulatory Roundup

November 2, 2011 By MassDevice staff

CoreValve

Medtronic (NYSE:MDT) implanted its CoreValve transcatheter aortic valve implantation system into the first patient in a Japanese clinical trial of the device’s safety and effectiveness.

The CoreValve system is a minimally invasive treatment option for patients with severe heart disease who are at high risk or unable to undergo open-heart surgery.

"With the number of aortic valve stenosis patients steadily rising as the Japanese population ages, we consider this an important step towards the introduction of a new therapeutic option to the health care system," lead surgeon and professor in the cardiovascular surgery department at Osaka University Hospital Dr. Yoshiki Sawa said in prepared remarks.

The device, currently limited to investigational use in the U.S., won approval from Korean regulators earlier this month and expanded CE Mark approval in the European Union in August, but is still years away from the U.S. market.

CoreValve "looks like a 2014 product for the U.S.," Medtronic executive VP and cardiac and vascular group president Michael Coyle said at an annual shareholders meeting in August.

That puts CoreValve two years behind competitor Edwards Lifesciences Corp.’s (NYSE:EW) Sapien valve, which got a positive FDA panel vote in July.

Edwards has staked its flag on an October 2011 release, sinking about $40 million into a launch that Edwards’ chairman & CEO Michael Mussallem said will allow the company to compete in 200 to 400 medical centers in the U.S. 

Edwards and Medtronic have gone back and forth over valve patent disputes, most recently resulting in a $74 million patent infringement loss for Medtronic. A federal judge denied Edwards’ move to bar U.S. manufacturing and sales of CoreValve, which Medtronic acquired in in its $700 million buyout of CoreValve Inc. in 2009.

Medtronic also announced a novel approach to minimally invasive spinal fusion allowing surgeons to access the spine in the lower back, according to a press release.

Regulatory Roundup

  • Claret Medical lands CE Mark
    Claret Medical Inc. announced today that its Montage System has received CE Mark approval as the world’s first complete system of filtration to protect both carotid arteries simultaneously. 
    Read more
  • Spinal implant company touts FDA clearance
    LDR, a privately held spinal implants company, announced that it received 510(k) clearance to market the ROI-A Oblique ALIF cage.
    Read more
  • Imaging3 completes second milestone toward FDA clearance
    "I am able to report to you that our October 17, 2011 meeting with the FDA went as anticipated and we have successfully completed the second milestone of our three phase submission process," Imaging3 (OTCBB: IMGG) chairman & CEO Dean James said in prepared remarks.
    Read more
  • ClearCount lands CE mark for SmartSponge
    ClearCount Medical Solutions announced received approval to affix the CE mark to its SmartSponge and SmartWand-DTX products. The SmartSponge product line is the first and only RFID-based surgical safety and efficiency technology bearing a CE mark, according to a press release.
    Read more
  • Brainsway wins IDE approval for bipolar disorder trial
    Brainsway (TASE:BRIN) received an Investigational Device Exemption approval from the FDA, allowing it to begin a multicenter clinical trial to evaluate the efficacy of its Deep TMS device in the treatment of subjects with bipolar disorder.
    Read more
  • Filed Under: Food & Drug Administration (FDA), News Well, Replacement Heart Valves Tagged With: Brainsway, Claret Medical Inc., ClearCount Medical Solutions, Clinical Trials, Imaging3

    More recent news

    • Aurora Spine begins first procedures with Aero lumbar fusion system
    • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
    • InspireMD launches carotid stent in U.S. after FDA approval
    • Neuros Medical raises $56M Series D to support nerve stim tech
    • CorWave reports first-in-human LVAD implant

    Primary Sidebar

    “md
    EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
    Get the latest med device regulatory, business and technology news.

    DeviceTalks Weekly

    See More >

    MEDTECH 100 Stock INDEX

    Medtech 100 logo
    Market Summary > Current Price
    The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
    MDO ad

    Footer

    MASSDEVICE MEDICAL NETWORK

    DeviceTalks
    Drug Delivery Business News
    Medical Design & Outsourcing
    Medical Tubing + Extrusion
    Drug Discovery & Development
    Pharmaceutical Processing World
    MedTech 100 Index
    R&D World
    Medical Design Sourcing

    DeviceTalks Webinars, Podcasts, & Discussions

    Attend our Monthly Webinars
    Listen to our Weekly Podcasts
    Join our DeviceTalks Tuesdays Discussion

    MASSDEVICE

    Subscribe to MassDevice E-Newsletter
    Advertise with us
    About
    Contact us

    Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
    The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

    Privacy Policy